Ligand Pharmaceuticals
LGND
116,40 €
Share price
-0.67%
Change (1 day)
15.80%
Change (1 year)
EPS for Ligand Pharmaceuticals (LGND)
EPS in 2025 (TTM): -6,65 €
According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -6,14 €. In 2024 the company made an earnings per share (EPS) of -0,04313 € a decrease over its 2023 EPS that were of 2,49 €.
EPS history for Ligand Pharmaceuticals from 2012 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | -6,65 € | 15320.57% |
| 2024 | -0,04313 € | -101.73% |
| 2023 | 2,49 € | -245.96% |
| 2022 | -1,71 € | -157.23% |
| 2021 | 2,98 € | -2571.43% |
| 2020 | -0,12 € | -100.46% |
| 2019 | 26,41 € | 353.48% |
| 2018 | 5,82 € | 1025% |
| 2017 | 0,52 € | -700% |
| 2016 | -0,08627 € | -100.87% |
| 2015 | 9,97 € | 1859.32% |
| 2014 | 0,51 € | 5.36% |
| 2013 | 0,48 € | 8.0704505322479E+18% |
| 2012 | 0,0000000000 € |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 9,53 € | -255.20% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | -0,31 € | -94.94% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 1,35 € | -121.91% | 🇬🇧 UK |
 Merck MRK | 5,95 € | -196.87% | 🇺🇸 USA |
 Pfizer PFE | 1,20 € | -119.52% | 🇺🇸 USA |
 Eli Lilly LLY | 10,66 € | -273.54% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,31 € | -137.64% | 🇺🇸 USA |
 Baxter BAX | -0,02588 € | -99.58% | 🇺🇸 USA |
 Johnson & Johnson JNJ | 7,82 € | -227.35% | 🇺🇸 USA |